This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Astrazeneca Ab, Hermes Pharma Gmbh. Active years: 2003-2025.
Company Filing History:
Years Active: 2003-2025
Title: Gerd Weiss: Innovator in Pharmaceutical Technologies
Introduction
Gerd Weiss is a notable inventor based in Munich, Germany, recognized for his contributions to pharmaceutical technologies. With a total of 3 patents, he has made significant advancements in the preparation of effervescent granules and stable medicaments for oral administration.
Latest Patents
One of his latest patents is a method for the preparation of effervescent granules. This invention provides a unique approach where reactive effervescent components are brought to reaction under stirring in a vacuum. The method ensures that the stirring speed in the mixing chamber maintains a Froude number of 0.5 or higher, optimizing the effervescent reaction process. Another significant patent involves a stable drug form for oral administration that includes benzimidazole derivatives as the active ingredient. This invention also outlines a method for producing the stable medicament, enhancing the efficacy of oral drugs.
Career Highlights
Throughout his career, Gerd Weiss has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Hermes Pharma. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Gerd Weiss has collaborated with notable professionals in the field, including Thomas Profitlich and Gerd-Ulfert Heese. These collaborations have further enriched his work and innovations in pharmaceutical technologies.
Conclusion
Gerd Weiss stands out as an influential inventor in the pharmaceutical sector, with a focus on innovative drug formulations and preparation methods. His contributions continue to impact the industry positively.